N@N

Glancy Binkow & Goldberg LLP Announces Investigation of HealthSpring, Inc.

^{Published on 2011-10-27 14:07:14 - Market Wire}
 

LOS ANGELES--([ BUSINESS WIRE ])--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims against the board of directors of HealthSpring, Inc. (aHealthSpringa or the aCompanya) (NYSE:HS), related to the Companyas agreement to be acquired by Cigna Corporation (aCignaa) in a proposed all-cash transaction. The proposed transaction is valued at approximately $3.8 billion.

Under the terms of the definitive agreement entered into by the parties, Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash. The transaction is expected to close during the first half of 2012. The investigation concerns whether the board of directors of HealthSpring breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction.

If you are a shareholder of HealthSpring, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, CA 90067, by telephone at (310) 201-9150 or Toll Free at (888) 773-9224 or by email to [ shareholders@glancylaw.com ].

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.